Severin Oliver Wendelspiess

Title: Severin Oliver Wendelspiess: Innovator in Antigen Binding Proteins

Introduction

Severin Oliver Wendelspiess is a notable inventor based in Zürich, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding proteins. His innovative work has led to the creation of valuable tools for research and therapeutic applications.

Latest Patents

Severin holds a patent for "Rabbit-derived antigen binding protein nucleic acid libraries and methods of making the same." This patent involves the provision of rabbit antigen binding protein nucleic acid libraries, which encode proteins that specifically recognize target peptide-MHC (pMHC). The methods for producing these libraries are also detailed in his patent, showcasing his expertise in this specialized area.

Career Highlights

Severin is currently associated with Cdr-life AG, a company focused on advancing biotechnological solutions. His role at the company allows him to apply his innovative ideas and contribute to the development of cutting-edge technologies in the field.

Collaborations

Severin has collaborated with talented individuals such as Anna Maria Sobieraj and Fabian Bert Scheifele. These collaborations have likely enriched his research and contributed to the success of his projects.

Conclusion

Severin Oliver Wendelspiess is a distinguished inventor whose work in antigen binding proteins has the potential to impact various scientific fields. His contributions continue to advance biotechnological research and applications.